Abstract
Human P2X2 receptors (hP2X2) are strongly inhibited by zinc over the range of 2-100 μM, whereas rat P2X2 receptors (rP2X2) are strongly potentiated over the same range, and then inhibited by zinc over 100 μM. However, the biological role of zinc modulation is unknown in either species. To identify candidate regions controlling zinc inhibition in hP2X2 a homology model based on the crystal structure of zebrafish P2X4.1 was made. In this model, His-204 and His-209 of one subunit were near His-330 of the adjacent subunit. Cross-linking studies confirmed that these residues are within 8 Å of each other. Simultaneous mutation of these three histidines to alanines decreased the zinc potency of hP2X2 nearly 100-fold. In rP2X2, one of these histidines is replaced by a lysine, and in a background in which zinc potentiation was eliminated, mutation of Lys-197 to histidine converted rP2X2 from low potency to high potency inhibition. We explored whether the zinc-binding site lies within the vestibules running down the central axis of the receptor. Elimination of all negatively charged residues from the upper vestibule had no effect on zinc inhibition. In contrast, mutation of several residues in the hP2X2 middle vestibule resulted in drama...Continue Reading
References
Oct 9, 1992·Science·M H AkabasA Karlin
Jan 18, 1996·European Journal of Pharmacology·K Nakazawa, Y Ohno
Apr 29, 1998·British Journal of Pharmacology·S S WildmanG Burnstock
Mar 19, 1999·Protein Science : a Publication of the Protein Society·I L AlbertsS J Wodak
Mar 8, 2002·The Journal of Physiology·J Dylan ClyneRichard I Hume
Sep 25, 2002·Physiological Reviews·R Alan North
Feb 27, 2003·Neuropharmacology·J D ClyneR I Hume
May 16, 2003·Pflügers Archiv : European journal of physiology·Richard D Palmiter, Liping Huang
Jan 8, 2004·European Journal of Pharmacology·Peter Illes, J Alexandre Ribeiro
Nov 19, 2004·International Review of Cytology·Geoffrey Burnstock, Gillian E Knight
May 19, 2005·The Journal of Biological Chemistry·Naomi NagayaRichard I Hume
Jun 18, 2005·The Journal of Physiology·Debra A CockayneAnthony P D W Ford
Nov 23, 2005·Bioinformatics·Konstantin ArnoldTorsten Schwede
Jan 18, 2006·Pharmacology & Therapeutics·Alistair MathieEmma L Veale
Jan 31, 2006·Experimental Neurology·C J FredericksonM H Zornow
Oct 31, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rachel K Tittle, Richard I Hume
Jan 3, 2009·Nature Nanotechnology
Jan 10, 2009·Nature Protocols·Lorenza BordoliTorsten Schwede
Jul 31, 2009·Nature·Toshimitsu KawateEric Gouaux
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
May 19, 2011·Advances in Pharmacology·Laszlo KölesPeter Illes
Jun 1, 2011·The Journal of General Physiology·Toshimitsu KawateKenton J Swartz
Jun 7, 2011·Reviews in the Neurosciences·Claudio CoddouJ Pablo Huidobro-Toro
Aug 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Damien S K SamwaysTerrance M Egan
Nov 2, 2011·PloS One·Claudia AndreiniGabriele Cavallaro
Nov 16, 2011·Frontiers in Behavioral Neuroscience·Carlos Sindreu, Daniel R Storm
Citations
Nov 1, 2012·PloS One·Shlomo S Dellal, Richard I Hume
Dec 5, 2012·PloS One·Selvan BavanSteven J Ennion
Aug 16, 2013·Antioxidants & Redox Signaling·Stanko S StojilkovicClaudio Coddou
Feb 11, 2015·FEBS Letters·Tatsuhiro IgawaTadashi Ueda
Jul 18, 2015·Neuropharmacology·Maria KowalskiPatrizia Rubini
Sep 27, 2013·Neuropharmacology·Sukanya Punthambaker, Richard I Hume
Jun 19, 2017·Neuroscience and Biobehavioral Reviews·Brendan B McAllister, Richard H Dyck
Aug 16, 2018·Cellular and Molecular Neurobiology·Liliana H Méndez-BarredoCarlos Barajas-López
Jan 19, 2021·Neuroscience·Rebecca F KrallElias Aizenman